Status:
COMPLETED
Role of Lung Ultrasound in Screening for Interstitial Lung Disease in Patients With Rheumatoid Arthritis
Lead Sponsor:
Assiut University
Conditions:
Interstitial Lung Disease
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this observational cross-sectional study is to assess accuracy of Lung Ultrasound to early diagnose ILD among Rheumatoid arthritis patients. Rheumatoid arthritis patients with suggestive hi...
Detailed Description
Interstitial lung disease (ILD) is a common complication of connective tissue disease (CTD) and a leading cause of morbidity and mortality. Thus, early diagnosis and treatment may improve the prognosi...
Eligibility Criteria
Inclusion
- Confirmed diagnosis of rheumatoid arthritis and suspicion of interstitial lung disease on history and/ or clinical examination, age \> 18 years
Exclusion
- Patients who refuse to participate in the study,
- Patients with a history of pulmonary neoplasia or
- Patients with causes of interstitial fluid, such as, heart failure, diastolic dysfunction, asthma or pulmonary edema.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06531785
Start Date
January 1 2024
End Date
August 1 2025
Last Update
August 28 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Faculty of Medicine, Assiut University
Asyut, Egypt, 711111